Consequences of a combined administration of different doses of aprotinin and autologous blood transfusions for coagulation and fluid replacement in cardiac surgery.
Gschossmann
J
J
Department of Cardiovascular Surgery, Augsburg Medical Center, Germany.
Pracki
P
P
Vicol
C
C
Struck
E
E
D007611:Aprotinin / Q000008:administration & dosage*; D001777:Blood Coagulation; D001804:Blood Transfusion, Autologous; D006348:Cardiac Surgical Procedures; D004311:Double-Blind Method; D005440:Fluid Therapy; D006452:Hemoglobinometry; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control; D010314:Partial Thromboplastin Time; D011183:Postoperative Complications / Q000517:prevention & control; D011517:Prothrombin Time
D007611:Aprotinin